Arkolith/Insider Trading/AKYA/Form 4

Bamford Pascal

Chief Clinical OfficerAkoya Biosciences, Inc. (AKYA) · full profile →Form 4 · filed Mar 4, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 1, 2025Tax withholding(F)1K$1.63$2K209K
Mar 1, 2025Tax withholding(F)3K$1.63$4K206K

Transaction Codes

F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-004357) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML